Congratulations to Penn Medicine - Abramson Cancer Center and Tara Miller Melanoma Center's Lynn Schuchter for being named an OncLive.com 2024 “Giant of Cancer Care” for #Melanoma & Other Skin Cancers, as a leading researcher who has propelled the field forward. spr.ly/6010jCI7O

It is a huge honor to be appointed as the co-director of the Penn Epigenetics. Look forward to learning from Berger Lab and blobellab. Dr. Marisa Bartolomei set a high standard for leadership that I aim to honor and build upon in the coming tenure. tinyurl.com/4jwwwntt

Congrats Kaechlab (Sue Kaech) !! So well-deserved!

Today, we announced the dosing of the first patient in our phase 1/2 trial of #AB2100 being studied as a potential treatment for clear cell renal cell carcinoma. #kidneycancer #celltherapy .  We are grateful for the team who worked tirelessly to achieve this important milestone

Congratulations Jeffrey Bluestone of @SonomaBio, newly inducted #NASmember ! #NAS161 #immunology

We are thrilled to see the work of Dr. Abhijeet Patil in
Cell
journal of Cell Reports Medicine reporting modeling of type 1 diabetes using single-cell data cell.com/cell-reports-m… Thanks to our collaborators at The Human Pancreas Analysis Program - HPAP HIRN

Congrats Miriam Merad, MD, PhD Well-deserved!!

Congratulations Prof. Akiko Iwasaki and thank you for all you do for Immunology

Our CEO, Ken Drazan, MD, will speak on a panel - CAR T in Solid Tumors - at the Canaccord Genuity 2024 Horizons in Oncology Conference on April 15, 2024 at 10am EDT. ArsenalBio is focused on developing a new generation of #celltherapy medicines to treat solid tumor cancers

Crazy—we took a quick look at our platform data to see if it supported how it 'feels' out there. 2024 is on trend for the lowest programs against 'new drug targets' in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new

Memory genes are enriched in CAR T cells that persist and control tumors in patients. But which transcription factors drive beneficial memory programs?

We answer this in our lab’s first paper in nature led by Alex Doan Kat Mueller, PhD Andy Chen. 1/

nature.com/articles/s4158…

UPenn medical school names first vice dean of AI inquirer.com/health/upenn-m… via The Philadelphia Inquirer

An incredible talk ⁦by ⁦rising star ⁦Jennifer Guerriero, PhD⁩ ⁦Dana-Farber⁩ #aacr24 AACR⁩ annual meeting on targeting macrophages in the context of parp inhibition 👏👏👏

Penn proud as John Maris and John Wherry inducted into the 2024 Class of AACR fellows which recognizes distinguished scientists who have made major scientific innovations. Congrats AACR Penn Medicine Penn Medicine - Abramson Cancer Center E. John Wherry

Celebrating ⁦AACR⁩ w ⁦Padmanee (Pam) Sharma, MD, PhD⁩ ⁦Jim Allison PhD⁩ ⁦Miriam Merad, MD, PhD⁩ ⁦Dr. Ron DePinho⁩ ⁦AACRPres⁩ Phil Greenberg ⁦Jennifer Guerriero, PhD⁩ Elaine Mardis Jim Heath Bob Schreiber

Arsenal Biosciences is pleased to be presenting this week at the AACR Annual Meeting 2024. We look forward to share learnings from our #cancerresearch programs. Read our press release for more details: arsenalbio.com/2024/04/05/ars…

My favorite quote.

'I don't have talent, so I just get up earlier.' – Henry Rollins

Please, reviewers and authors:

Let’s not be ok with arbitrary flow cytometry gates that cut across normally distributed clusters. Even though flow cytometry is a single-cell assay, the data interpretation is largely at a population level because of variation in photon

Jane Yinghui Huang from the Wherry lab E. John Wherry defends tomorrow!

Some big news - I’m headed to Mass General Brigham Harvard Medical School Combined Derm Program for my residency training!

I owe everything to the amazing people at Penn Medicine (s/o E. John Wherry lab), PD Soros Fellowships, and my family + friends who made this possible

#Match2024